Agios Pharmaceuticals | Nettoeinkommen



Net Income Veränderung Datum
AbbVie USD 1.29B 1.31B 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
Alnylam Pharmaceuticals USD -66277000 8.8M 2025-06
Amgen USD 1.73B 1.1B 2025-03
Arrowhead Research USD 370.44M 543.53M 2025-03
Astellas Pharma JPY 68.42B 6.47B 2025-06
AstraZeneca USD 2.45B 466M 2025-06
Bayer EUR 1.3B 1.63B 2025-03
Biogen USD 634.8M 394.3M 2025-06
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Daiichi Sankyo JPY 85.5B 1.65B 2025-06
Eli Lilly USD 2.76B 1.65B 2025-03
Exelixis USD 230.42M 70.8M 2025-07
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.44B 181M 2025-06
Incyte USD 405M 246.8M 2025-06
Ionis Pharmaceuticals USD 123.55M 270.49M 2025-06
Merck USD 4.43B 652M 2025-06
Moderna USD -971000000 149M 2025-03
Novartis USD 4.02B 418M 2025-06
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12


Agios Pharmaceuticals Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.